Navigation Links
Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
Date:10/28/2008

ORANGE COUNTY, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), announced today that it has signed new sole source agreements with Adventist Health to provide a broad range of core laboratory systems and supplies valued at approximately $36 million over six years. Adventist Health is a not-for-profit, faith-based health care system with facilities in California, Hawaii, Oregon, and Washington.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

Under the terms of the new six-year agreements, Adventist Health hospital laboratories will continue to purchase hematology products from Beckman Coulter, and will add the company's complete line of automated chemistry and immunoassay analyzers and reagents to their owned, leased and managed facilities. An expanding group of more than 38 acute-care affiliate organizations will also be able to purchase systems under the contract.

In making the decision, Adventist Health cited Beckman Coulter's ability to deliver cutting-edge technologies that can help their physicians deliver prompt and effective patient care. Lowell Church, assistant vice president, said, "We are constantly striving to enhance quality care, increase patient safety and improve outcomes, in addition to controlling costs. Beckman Coulter has the same vision and goals and we look forward to collaborating with them."

David Bespalko, corporate vice president of sales in North America for Beckman Coulter, said about the contract, "These agreements are a great opportunity to continue to demonstrate our commitment to improving patient health and reducing the cost of care. Our innovative systems sim
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
2. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
3. Beckman Coulter Investor Events Second Half of 2008
4. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
5. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
6. Beckman Coulter Announces Second Quarter 2008 Results
7. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
8. Upcoming Beckman Coulter Investor Events Second Half of 2008
9. Beckman Coulter to Present at Upcoming Healthcare Conferences
10. Beckman Coulter Announces First Quarter 2008 Results
11. Beckman Coulter Acquires Rights to Hepatitis C Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015   Neuraltus Pharmaceuticals, Inc. , a ... groundbreaking drugs to treat neurodegenerative diseases such as ... Robert G. Miller , M.D., Director of the Forbes ... Pacific Medical Center in San Francisco, has been awarded ... million to help fund a Phase 2 clinical ...
(Date:7/1/2015)... InferMed , s decision ... augment Elsevier ... suite   Elsevier , a world-leading provider ... today the acquisition of  InferMed , a London ... InferMed,s Arezzo technology supports clinicians in choosing the most appropriate ...
(Date:6/30/2015)... , July 1, 2015 R-Japan Co.,Ltd. obtained ... the Safety of Regenerative Medicine from the Ministry of Health, ... June 29, 2015. The fact that R- ... facility through the auditing from Pharmaceuticals and Medical Devices Agency ... application, allows it to provide stem cell manufacturing service to ...
(Date:6/30/2015)... 30, 2015  NASA astronaut Kjell Lindgren , who ... his first mission to the International Space Station , ... 9 a.m. EDT Tuesday, July 7. Lindgren will ... Russia . The interviews will be preceded ... his mission training. To schedule an interview, media ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2
... BOTHELL, Wash., Aug. 7 SCOLR Pharma, Inc. (NYSE Amex: ... and six months ended June 30, 2009. , ... said, "We continue to advance discussions with a number of potential ... been committing resources to due diligence and preliminary negotiations of license ...
... , HUNTSVILLE, Ala., Aug. 7 ... acid therapeutics and delivery, announced today that Jason Fewell, Ph.D., ... Vice-President of Preclinical Research and Development. , , ... scientific leadership experience in the biotechnology industry and has served ...
... BRISBANE, Calif., Aug. 7 InterMune, Inc. (Nasdaq: ITMN ... President of InterMune, will present at the Canaccord Adams 29th Annual ... a.m. EDT. , , To access a live ... log on to the investor relations page of InterMune,s corporate website ...
Cached Biology Technology:SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results 8EGEN, Inc. Announces the Promotion of Jason Fewell, Ph.D., to Vice-President of Preclinical Research and Development 2
(Date:6/16/2015)... 16, 2015  With the increasing number and severity ... top concern. The recent compromise of Federal employee ... strong authentication within government agencies. HYPR Corp. ... password (OTP) authenticator, has been submitted for testing and ... 3 validation for tamper proofing. The ...
(Date:6/15/2015)... DALLAS , June 16, 2015 ... Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), ... Worldwide Forecast to 2020" published by MarketsandMarkets, The Natural ... Billion at a CAGR of 18.4% for the forecast ... Tables and   46 F igures spread   ...
(Date:6/12/2015)... , June 12, 2015  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... its patent to electronically capture, analyze and identify ... facial recognition methods. This system can: ... by an enrollment and subsequent sign-on process is ...
Breaking Biology News(10 mins):Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... Following the Clean Air Act Amendments of 1970 and ... since its peak in 1973. Consequently, research has shifted ... recovery of these aquatic and terrestrial ecosystems. Regional-scale studies ... of these ecosystems are showing signs of chemical recovery ...
... JANUARY 12, 2009 - With recent increase in the ... sources, the increased harvest of corn residue for cellulosic ... be especially true in fields where corn is grown ... annual harvests, and also because corn residue left on ...
... edition of the journal Current Biology , Instituto ... mystery in cell biology, and offer up new clues ... Dias, working with researchers at the universities of Cambridge, ... cells count the number of centrosomes, the structure that ...
Cached Biology News:Organic soils continue to acidify despite reduction in acidic deposition 2Preventing soil erosion in continuous corn 2How do cells count? 2
... (5-bromo-4-chloro-3-indoyl-beta-D-galactopyranoside) is a chromogenic ... recombinant plasmids. In the ... IPTG, lac + ... whereas recombinant colonies appear ...
... fully flexible quadrupole MS detector optimized for ... 1-D and 2-D LC, as well as ... a drying gas system to create a ... for low-to-medium polarity compounds, while providing for ...
... PsiPort Mass Directed Auto Purification software, ... acquisition system designed for automated compound ... science and pharmaceutical discovery programs. The ... simplify high throughput mass directed auto ...
Miniature FRENCH Pressure Cell with 3.7ml capacity; pressure up to 20,000 psi....
Biology Products: